Genotypes of Staphylococcus aureus Clinical Isolates Are Associated with Phenol-Soluble Modulin (PSM) Production

Toxins (Basel). 2022 Aug 15;14(8):556. doi: 10.3390/toxins14080556.

Abstract

Phenol-soluble modulins (PSMs) are important S. aureus virulence factors that cause cytolysis, mast cell degranulation, and stimulate inflammatory responses. In this study, PSM production by S. aureus clinical isolates was measured by liquid chromatography/mass spectrometry (LC-MS) and correlated with staphylococcal protein A (spa) type and staphylococcal cassette chromosome mec (SCCmec) type. Of 106 S. aureus clinical isolates, 50 (47.2%) corresponded to methicillin-susceptible S. aureus (MSSA) and 56 (52.8%) to methicillin-resistant S. aureus (MRSA). LC-MS analysis revealed no significant difference in average PSMα3, PSMα4, PSMβ2, and δ-toxin production between MSSA and MRSA isolates, but PSMα1, PSMα2, and PSMβ1 production were higher in MSSA than MRSA. This study demonstrated that average PSMα1-α4, PSMβ1-β2, and δ-toxin production by SCCmec type II strains was significantly lower than the IV, IVA, and V strains. Most of the SCCmec type II strains (n = 17/25; 68.0%) did not produce δ-toxin, suggesting a dysfunctional Agr system. The spa type t111 (except one strain) and t2460 (except one strain producing PSM α1-α4) did not produce PSMα1-α4 and δ-toxin, while average PSM production was higher among the t126 and t1784 strains. This study showed that the genotype of S. aureus, specifically the spa and SCCmec types, is important in characterizing the production of PSMs.

Keywords: MRSA; MSSA; PSMs; SCCmec type; Staphylococcus aureus; delta-toxin; mass spectrometry; spa type.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Genotype
  • Methicillin-Resistant Staphylococcus aureus
  • Microbial Sensitivity Tests
  • Staphylococcal Infections* / microbiology
  • Staphylococcal Protein A
  • Staphylococcus aureus / genetics
  • Staphylococcus aureus / metabolism

Substances

  • Staphylococcal Protein A
  • staphylococcal delta toxin

Grants and funding

This research was supported by the Bio and Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government, Ministry of Science and ICT (MSIT) 2017M3A9E4077232. This study was also supported by the Hallym University research fund.